Study to Evaluate Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Peripheral Neuropathic Pain
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Richard L Leff, md
AstraZeneca R&D Wilmington, USA
Study Director - Rolf Karlsten, MD
AstraZeneca R&D Södertälje, Sweden
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Calgary, Alberta, Canada
- Research Site
Halifax, Nova Scotia, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Aalborg, Denmark
- Research Site
Arhus C, Denmark
- Research Site
Boulogne-Billancourt, France
- Research Site
Clermont-Ferrand, France
- Research Site
Nice, France
- Research Site
Bradford, United Kingdom
- Research Site
Glasgow, United Kingdom
- Research Site
London, United Kingdom
- Research Site
Manchester, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2009
- Primary completion
- —
- Completion
- 28 Feb 2010
- Last update posted
- 23 Dec 2009
- Registered enrollment
- 90
- Registry id
- NCT00976534
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.